Company
ETRA · CIK 0002088082
Acquisition (code C) of 2,002,310 shares; price not stated (see filing).
Reporting Persons ORBIMED ADVISORS LLC · OrbiMed Capital GP VII LLC · OrbiMed Genesis GP LLC · Transaction Code C
Traded Sep 21, 2026 · Disclosed Sep 23, 2026
Source: SEC Form 4 · 0000947871-26-000880 · filed 2026-09-23 · View filing →
Acquisition (code C) of 1,087,934 shares; price not stated (see filing).
Reporting Persons ORBIMED ADVISORS LLC · OrbiMed Capital GP VII LLC · OrbiMed Genesis GP LLC · Transaction Code C
Traded Sep 21, 2026 · Disclosed Sep 23, 2026
Source: SEC Form 4 · 0000947871-26-000880 · filed 2026-09-23 · View filing →
Acquisition (code C) of 1,703,314 shares; price not stated (see filing).
Reporting Persons ORBIMED ADVISORS LLC · OrbiMed Capital GP VII LLC · OrbiMed Genesis GP LLC · Transaction Code C
Traded Sep 21, 2026 · Disclosed Sep 23, 2026
Source: SEC Form 4 · 0000947871-26-000880 · filed 2026-09-23 · View filing →
Acquisition (code C) of 758,279 shares; price not stated (see filing).
Reporting Persons ORBIMED ADVISORS LLC · OrbiMed Capital GP VII LLC · OrbiMed Genesis GP LLC · Transaction Code C
Traded Sep 21, 2026 · Disclosed Sep 23, 2026
Source: SEC Form 4 · 0000947871-26-000880 · filed 2026-09-23 · View filing →
Acquisition (code C) of 2,002,310 shares; price not stated (see filing).
Reporting Person GORDON CARL L · Transaction Code C
Traded Sep 21, 2026 · Disclosed Sep 23, 2026
Source: SEC Form 4 · 0000947871-26-000881 · filed 2026-09-23 · View filing →
Acquisition (code C) of 1,087,934 shares; price not stated (see filing).
Reporting Person GORDON CARL L · Transaction Code C
Traded Sep 21, 2026 · Disclosed Sep 23, 2026
Source: SEC Form 4 · 0000947871-26-000881 · filed 2026-09-23 · View filing →
Acquisition (code C) of 1,703,314 shares; price not stated (see filing).
Reporting Person GORDON CARL L · Transaction Code C
Traded Sep 21, 2026 · Disclosed Sep 23, 2026
Source: SEC Form 4 · 0000947871-26-000881 · filed 2026-09-23 · View filing →
Acquisition (code C) of 758,279 shares; price not stated (see filing).
Reporting Person GORDON CARL L · Transaction Code C
Traded Sep 21, 2026 · Disclosed Sep 23, 2026
Source: SEC Form 4 · 0000947871-26-000881 · filed 2026-09-23 · View filing →
Purchase of 2,666,666 shares across 2 reporting persons.
Transaction Code P · Reporting Persons 2
Surfaced by rule: 2 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.
Traded Sep 21, 2026 · Disclosed Sep 23, 2026
Source: SEC Form 4 · 0000947871-26-000880 · filed 2026-09-23 · View filing →
Source: SEC Form 4 · 0000947871-26-000881 · filed 2026-09-23 · View filing →
Acquisition (code C) of 255,635 shares; price not stated (see filing).
Reporting Person Stagliano Nancy · Transaction Code C
Traded Sep 21, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001817449-26-000009 · filed 2026-09-21 · View filing →
Acquisition (code C) of 455,484 shares; price not stated (see filing).
Reporting Person Dong Quehuong (Kathy) · Officer Title President & CEO · Transaction Code C
Traded Sep 21, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0002153364-26-000004 · filed 2026-09-21 · View filing →
Acquisition (code C) of 63,656 shares; price not stated (see filing).
Reporting Person Koe Gary S. · Officer Title Chief Technical Officer · Transaction Code C
Traded Sep 21, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0002153365-26-000004 · filed 2026-09-21 · View filing →
Acquisition (code C) of 85,504 shares; price not stated (see filing).
Reporting Person Parry Graham · Officer Title Chief Scientific Officer · Transaction Code C
Traded Sep 21, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0002153366-26-000006 · filed 2026-09-21 · View filing →